TABLE OF CONTENT: 1. Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. Key Insights 4.1. Prevalence of Bacterial Skin Infections- By key countries,2018 4.2. New Product Launch 4.3. Pipeline Analysis 4.4. Key Industry Developments - Mergers, Acquisitions, and Partnerships, 2018 5. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Analysis, Insights and Forecast, 2015-2026 5.1. Key Findings / Summary 5.2. Market Analysis, Insights and Forecast – By Infection Type 5.2.1. Hospital-acquired ABSSSI 5.2.2. Community-acquired ABSSSI 5.3. Market Analysis, Insights and Forecast – By Route of Administration 5.3.1. Oral 5.3.2. Parenteral 5.4. Market Analysis, Insights and Forecast – By Distribution Channel 5.4.1. Hospital Pharmacy 5.4.2. Retail Pharmacy 5.4.3. Online Pharmacy 5.5. Market Analysis, Insights and Forecast – By Region 5.5.1. North America 5.5.2. Europe 5.5.3. Asia Pacific 5.5.4. Latin America 5.5.5. Middle East & Africa 6. North America Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Analysis, Insights and Forecast, 2015-2026 6.1. Key Findings / Summary 6.2. Market Analysis, Insights and Forecast – By Infection Type 6.2.1. Hospital-acquired ABSSSI 6.2.2. Community-acquired ABSSSI 6.3. Market Analysis, Insights and Forecast – By Route of Administration 6.3.1. Oral 6.3.2. Parenteral 6.4. Market Analysis, Insights and Forecast – By Distribution Channel 6.4.1. Hospital Pharmacy 6.4.2. Retail Pharmacy 6.4.3. Online Pharmacy 6.5. Market Analysis, Insights and Forecast – By Country 6.5.1. U.S. 6.5.2. Canada 7. Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Analysis, Insights and Forecast, 2015-2026 7.1. Key Findings / Summary 7.2. Market Analysis, Insights and Forecast – By Infection Type 7.2.1. Hospital-acquired ABSSSI 7.2.2. Community-acquired ABSSSI 7.3. Market Analysis, Insights and Forecast – By Route of Administration 7.3.1. Oral 7.3.2. Parenteral 7.4. Market Analysis, Insights and Forecast – By Distribution Channel 7.4.1. Hospital Pharmacy 7.4.2. Retail Pharmacy 7.4.3. Online Pharmacy 7.5. Market Analysis, Insights and Forecast – By Country/Sub-Region 7.5.1. U.K. 7.5.2. Germany 7.5.3. France 7.5.4. Spain 7.5.5. Italy 7.5.6. Scandinavia 7.5.7. Rest of Europe 8. Asia Pacific Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Analysis, Insights and Forecast, 2015-2026 8.1. Key Findings / Summary 8.2. Market Analysis, Insights and Forecast – By Infection Type 8.2.1. Hospital-acquired ABSSSI 8.2.2. Community-acquired ABSSSI 8.3. Market Analysis, Insights and Forecast – By Route of Administration 8.3.1. Oral 8.3.2. Parenteral 8.4. Market Analysis, Insights and Forecast – By Distribution Channel 8.4.1. Hospital Pharmacy 8.4.2. Retail Pharmacy 8.4.3. Online Pharmacy 8.5. Market Analysis, Insights and Forecast – By Country/Sub-Region 8.5.1. Japan 8.5.2. China 8.5.3. India 8.5.4. Australia 8.5.5. Southeast Asia 8.5.6. Rest of Asia Pacific 9. Latin America Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Analysis, Insights and Forecast, 2015-2026 9.1. Key Findings / Summary 9.2. Market Analysis, Insights and Forecast – By Infection Type 9.2.1. Hospital-acquired ABSSSI 9.2.2. Community-acquired ABSSSI 9.3. Market Analysis, Insights and Forecast – By Route of Administration 9.3.1. Oral 9.3.2. Parenteral 9.4. Market Analysis, Insights and Forecast – By Distribution Channel 9.4.1. Hospital Pharmacy 9.4.2. Retail Pharmacy 9.4.3. Online Pharmacy 9.5. Market Analysis, Insights and Forecast – By Country/Sub-Region 9.5.1. Brazil 9.5.2. Mexico 9.5.3. Rest of Latin America 10 Middle East & Africa Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Analysis, Insights and Forecast, 2015-2026 10.1. Key Findings / Summary 10.2. Market Analysis, Insights and Forecast – By Infection Type 10.2.1. Hospital-acquired ABSSSI 10.2.2. Community-acquired ABSSSI 10.3. Market Analysis, Insights and Forecast – By Route of Administration 10.3.1. Oral 10.3.2. Parenteral 10.4. Market Analysis, Insights and Forecast – By Distribution Channel 10.4.1. Hospital pharmacy 10.4.2. Retail Pharmacy 10.4.3. Online Pharmacy 10.5. Market Analysis, Insights and Forecast – By Country/Sub-Region 10.5.1. GCC Countries 10.5.2. South Africa 10.5.3. Rest of Middle East & Africa 11. Competitive Analysis 11.1. Key Industry Developments 11.2. Global Market Share Analysis (2018) 11.3. Company Profiles (Overview, Products & services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability)) 11.3.1. Merck & Co., Inc. 11.3.2. Pfizer Inc. 11.3.3. MELINTA THERAPEUTICS, INC. 11.3.4. ALLERGAN 11.3.5. Paratek Pharmaceuticals, Inc. 11.3.6. Cumberland Pharmaceuticals Inc. 11.3.7. Teva Pharmaceutical Industries Ltd. 11.3.8. Others 12. Strategic Recommendations

Merck & Co., Inc. Pfizer Inc. MELINTA THERAPEUTICS, INC. ALLERGAN Paratek Pharmaceuticals, Inc. Cumberland Pharmaceuticals Inc. Teva Pharmaceutical Industries Ltd. Other prominent players